Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma

Abstract

Oral propranolol administered beyond 6 months and up to 12 months of age meaningfully increases the success rate in high-risk IH. Success was sustained in most patients up to 3 months after stopping treatment. Retreatment was efficacious, and the safety profile satisfactory.